130 related articles for article (PubMed ID: 26374652)
21. Truxillic acid derivatives act as peroxisome proliferator-activated receptor gamma activators.
Steri R; Rupp M; Proschak E; Schroeter T; Zettl H; Hansen K; Schwarz O; Müller-Kuhrt L; Müller KR; Schneider G; Schubert-Zsilavecz M
Bioorg Med Chem Lett; 2010 May; 20(9):2920-3. PubMed ID: 20347594
[TBL] [Abstract][Full Text] [Related]
22. QSAR analysis of PPAR-gamma agonists as anti-diabetic agents.
Dixit A; Saxena AK
Eur J Med Chem; 2008 Jan; 43(1):73-80. PubMed ID: 17482722
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists.
Darwish KM; Salama I; Mostafa S; Gomaa MS; Helal MA
Eur J Med Chem; 2016 Feb; 109():157-72. PubMed ID: 26774923
[TBL] [Abstract][Full Text] [Related]
24. Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists.
Maltarollo VG; Togashi M; Nascimento AS; Honorio KM
PLoS One; 2015; 10(3):e0118790. PubMed ID: 25767888
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, activity, and docking study of phenylthiazole acids as potential agonists of PPARγ.
Ma L; Wang T; Shi M; Ye H
Drug Des Devel Ther; 2016; 10():1807-15. PubMed ID: 27313447
[TBL] [Abstract][Full Text] [Related]
26. Biological evaluation and structural insights for design of subtype-selective peroxisome proliferator activated receptor-α (PPAR-α) agonists.
Gangwal RP; Damre MV; Das NR; Sharma SS; Sangamwar AT
Bioorg Med Chem Lett; 2015 Jan; 25(2):270-5. PubMed ID: 25491112
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of selected 3D virtual screening tools for the prospective identification of peroxisome proliferator-activated receptor (PPAR) γ partial agonists.
Kaserer T; Obermoser V; Weninger A; Gust R; Schuster D
Eur J Med Chem; 2016 Nov; 124():49-62. PubMed ID: 27560282
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4(3H)-one derivatives as potential PPARγ and SUR agonists.
Ibrahim MK; Eissa IH; Alesawy MS; Metwaly AM; Radwan MM; ElSohly MA
Bioorg Med Chem; 2017 Sep; 25(17):4723-4744. PubMed ID: 28720328
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists.
Nazreen S; Alam MS; Hamid H; Yar MS; Shafi S; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Ali Y; Kharbanda C; Pillai KK
Eur J Med Chem; 2014 Nov; 87():175-85. PubMed ID: 25255433
[TBL] [Abstract][Full Text] [Related]
30. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer.
Lokhande KB; Ballav S; Yadav RS; Swamy KV; Basu S
J Biomol Struct Dyn; 2022 Feb; 40(3):971-981. PubMed ID: 32954977
[TBL] [Abstract][Full Text] [Related]
31. A computational study to identify the key residues of peroxisome proliferator-activated receptor gamma in the interactions with its antagonists.
Sharifi T; Ghayeb Y
J Biomol Struct Dyn; 2018 May; 36(7):1822-1833. PubMed ID: 28566016
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of marine fungal phthalide derivatives as PPAR-γ agonists.
Xiao B; Yin J; Park M; Liu J; Li JL; Kim EL; Hong J; Chung HY; Jung JH
Bioorg Med Chem; 2012 Aug; 20(16):4954-61. PubMed ID: 22819190
[TBL] [Abstract][Full Text] [Related]
33. Docking, synthesis and anti-diabetic activity of novel sulfonylhydrazone derivatives designed as PPAR-gamma agonists.
Zapata-Sudo G; Lima LM; Pereira SL; Trachez MM; da Costa FP; Souza BJ; Monteiro CE; Romeiro NC; D'Andrea ÉD; Sudo RT; Barreiro EJ
Curr Top Med Chem; 2012; 12(19):2037-48. PubMed ID: 23167793
[TBL] [Abstract][Full Text] [Related]
34. Uncovering PPAR-γ agonists: An integrated computational approach driven by machine learning.
Haider S; Shafiq M; Siddiqui AR; Sardar M; Mushtaq M; Shafeeq S; Nur-E-Alam M; Ahmad A; Ul-Haq Z
J Mol Graph Model; 2024 Jun; 129():108742. PubMed ID: 38422823
[TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis and in Combo Antidiabetic Bioevaluation of Multitarget Phenylpropanoic Acids.
Colín-Lozano B; Estrada-Soto S; Chávez-Silva F; Gutiérrez-Hernández A; Cerón-Romero L; Giacoman-Martínez A; Almanza-Pérez JC; Hernández-Núñez E; Wang Z; Xie X; Cappiello M; Balestri F; Mura U; Navarrete-Vazquez G
Molecules; 2018 Feb; 23(2):. PubMed ID: 29415496
[TBL] [Abstract][Full Text] [Related]
36. Ligand-induced stabilization and activation of peroxisome proliferator-activated receptor gamma.
Gani OA; Sylte I
Chem Biol Drug Des; 2008 Jul; 72(1):50-7. PubMed ID: 18554251
[TBL] [Abstract][Full Text] [Related]
37. Isomeric C12-alkamides from the roots of Echinacea purpurea improve basal and insulin-dependent glucose uptake in 3T3-L1 adipocytes.
Kotowska D; El-Houri RB; Borkowski K; Petersen RK; Fretté XC; Wolber G; Grevsen K; Christensen KB; Christensen LP; Kristiansen K
Planta Med; 2014 Dec; 80(18):1712-20. PubMed ID: 25371981
[TBL] [Abstract][Full Text] [Related]
38. Exploring conformational changes of PPAR-Ɣ complexed with novel kaempferol, quercetin, and resveratrol derivatives to understand binding mode assessment: a small-molecule checkmate to cancer therapy.
Lokhande KB; Ballav S; Thosar N; Swamy KV; Basu S
J Mol Model; 2020 Aug; 26(9):242. PubMed ID: 32816149
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of 6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid derivatives as PPARgamma activators.
Kumar R; Mittal A; Ramachandran U
Bioorg Med Chem Lett; 2007 Aug; 17(16):4613-8. PubMed ID: 17574414
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone.
Wang XJ; Zhang J; Wang SQ; Xu WR; Cheng XC; Wang RL
Drug Des Devel Ther; 2014; 8():2255-62. PubMed ID: 25422585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
